David Shaw’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-26,500
Closed -$5.05M 4849
2023
Q4
$5.05M Hold
26,500
﹤0.01% 1896
2023
Q3
$5.28M Hold
26,500
0.01% 1766
2023
Q2
$7.56M Buy
26,500
+11,300
+74% +$3.14M 0.01% 1567
2023
Q1
$3.3M Sell
15,200
-7,400
-33% -$1.44M ﹤0.01% 2305
2022
Q4
$4.65M Hold
22,600
0.01% 2168
2022
Q3
$6.28M Buy
+22,600
New +$5.75M 0.01% 1824
2022
Q2
Sell
-2,200
Closed -$456K 5901
2022
Q1
$456K Sell
2,200
-20,000
-90% -$3.3M ﹤0.01% 4426
2021
Q4
$3.96M Buy
22,200
+12,200
+122% +$2.41M ﹤0.01% 2646
2021
Q3
$2.06M Buy
10,000
+7,000
+233% +$1.37M ﹤0.01% 3013
2021
Q2
$569K Sell
3,000
-4,800
-62% -$786K ﹤0.01% 3966
2021
Q1
$1.02M Buy
+7,800
New +$936K ﹤0.01% 3095

Other funds holding SWAV

David Shaw's SWAV Position: Q1 2024 in Review

David Shaw sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q1 2024, closing a stake of 1,617 shares — an estimated $397K sold.

David Shaw first reported a position in SWAV in Q2 2020 and held it in 14 quarters. The position peaked at $38.8M in Q2 2021. 488 funds tracked by Wall St. Rank hold SWAV as of Q1 2024.

  • David Shaw reported no remaining Shockwave Medical, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • David Shaw sold 1,617 Shockwave Medical, Inc. Common Stock shares in Q1 2024, an estimated $397K.
  • David Shaw first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2020 and held it in 14 quarters.
  • David Shaw's Shockwave Medical, Inc. Common Stock position peaked at $38.8M in Q2 2021.
  • 488 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q1 2024.

Based on D.E. Shaw & Co's 13F filing for Q1 2024, filed 15 May 2024.